Skip to main content

Market Overview

Obalon Surges 470% On ReShape Lifesciences Merger Agreement

Share:
Obalon Surges 470% On ReShape Lifesciences Merger Agreement

Obalon Therapeutics Inc (NASDAQ: OBLN) shares are trading higher Wednesday after the company announced a merger agreement with ReShape Lifesciences.

Obalon Therapeutics is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes Obalon Balloon System. Geographically, it derives a majority of revenue from the United States.

Obalon Therapeutics shares were trading up 472.67% at $9.22 at publication time. The stock has a 52-week high of $9.70 and a 52-week low of 62 cents.

 

Related Articles (OBLN)

View Comments and Join the Discussion!

Posted-In: why it's movingM&A News Movers Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com